Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

10.44 USD -1.40 (-11.82%)
Official Closing Price Updated: 7:55 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,473,000
Open 11.49
Bid (Size) 10.52 (1)
Ask (Size) 10.70 (1)
Prev. Close 11.84
Today's Range 10.42 - 11.79
52wk Range 2.500 - 14.62
Shares Outstanding 47,246,847
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aldeyra Therapeutics Reports Full-Year 2020 Financial Results and Recent Business Highlights
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
Aldeyra Therapeutics to Present at the OIS Dry Eye Innovation Showcase on March 11, 2021
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and Chief Executive Officer Todd C. Brady, M.D., Ph.D. will discuss the potential of reproxalap as a novel,... 
From Business Wire News Releases

Performance

YTD
+59.88%
+59.88%
1 Month
-9.14%
-9.14%
3 Month
-11.45%
-11.45%
6 Month
+37.55%
+37.55%
1 Year
+292.48%
+292.48%

More News

Read More
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Full-Year 2020 Financial Results and Discuss Recent Business Highlights
From Business Wire News Releases
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
From Business Wire News Releases
Analysts Anticipate FDM To Hit $70
Tags ETFs
From ETF Channel
Aldeyra Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
From Business Wire News Releases
First Week of May 21st Options Trading For Aldeyra Therapeutics (ALDX)
Tags Stocks
From Market News Video
Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design
From Business Wire News Releases
Analysts Anticipate FDM Will Reach $64
Tags ETFs
From ETF Channel
Aldeyra Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Business Wire News Releases
Aldeyra Therapeutics (ALDX) Q4 2020 Earnings Call Transcript
Tags Market News ALDX
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.